CAre of Patients With PArenteral Nutrition At Home

Crohn's Disease Clinical Trial

— CAPANAH  

Official title:

Prospective Non-interventional Non-controlled Multicenter Observational Study to Evaluate the Quality of Care for Adult Patients on Home Parenteral Nutrition (HPN)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01545063
• Other study ID #: S54137
• Status: Completed
• Phase: N/A
• First received: March 1, 2012
• Last updated: July 18, 2017
• Start date: May 2012
• Est. completion date: April 2013

Study information

• Verified date: July 2017
• Source: Katholieke Universiteit Leuven
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This research aims to give an overview of a number of aspects related to the quality of care for adult patients on home parenteral nutrition.

Concretely this study follows up different aspects on different moments in the care of the patient pathways:

• process indicators concerning indication, parenteral nutrition, training, team access roads and the succession of complications

• Outcome indicators

• the health-related quality of life

• discrepancies in medication use

• the role of the different health care providers

Description:

Adult patients on HPN will be contacted by phone at three different time moments after their discharge to ask them about indicators, quality of life and discrepancies in medication use. After the follow-up, medical dossiers will be consulted to know which indicators are followed in practice.

The role of the different health care providers will be investigated by face-to-face interviews with different healthcare professionals.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 39
• Est. completion date: April 2013
• Est. primary completion date: April 2013
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients in Flanders who speak Dutch, are older then 18 years and are able to give an informed consent.

Exclusion Criteria:

• Patients who are younger then 18 years.

Related Conditions & MeSH terms

• Carcinoma
• Chronic Diarrhea
• Crohn Disease
• Crohn's Disease
• Diarrhea
• Enteritis
• Intestinal Lymphomas
• Intestinal Obstruction
• Peritoneal Carcinomatosis With Intestinal Occlusion
• Radiation Enteritis

Locations

Country	Name	City	State
Belgium	Antwerpen Middelheim	Antwerpen
Belgium	UZA Antwerpen Edegem	Antwerpen
Belgium	Imelda Ziekenhuizen Bonheide	Bonheiden
Belgium	AZ Sint-Lucas	Brugge
Belgium	University Centrum Brussel	Brussel
Belgium	AZ Sint Blasius Dendermonde	Dendermonde
Belgium	Ziekenhuis Oost Limburg	Genk
Belgium	AZ Sint Lucas en Volkskliniek	Gent
Belgium	UZ Gent	Gent
Belgium	Hasselt Jessa Ziekenhuizen	Hasselt
Belgium	Catholic University	Leuven
Belgium	AZ Damiaan	Oostende
Belgium	Heilig Hart vzw	Roeselare Menen

Sponsors (12)

Lead Sponsor	Collaborator
Katholieke Universiteit Leuven	AZ Damiaan, Oostende, AZ Sint-Blasius Dendermonde, AZ Sint-Lucas, H.-Hartziekenhuis Roeselare-Menen vzw, Imelda Hospital, Bonheiden, Jessa Hospital, Universitair Ziekenhuis Brussel, Universiteit Antwerpen, University Hospital, Ghent, Ziekenhuis Netwerk Antwerpen (ZNA), Ziekenhuis Oost-Limburg

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of life	Quality of life will be investigated with the HPN-QoL(r) or FACIT-G (r).	2 years
Primary	Number of catheter related infections		2 years